The Ethics of Right to Try Investigational Agents in Oncology—Balancing Hope With Evidence

This Viewpoint discusses the ethical implications of Right to Try access to investigational oncology agents for patients and physicians.

Corresponding Author: Yue Wang, MD, Department of General Surgery, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital wangyue1@cancerhosp-ln-cmu.com).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.